跳至主要内容
临床试验/NCT04198467
NCT04198467已完成2 期

Randomized Controlled Study to Compare Safety and Efficacy of Intra Articular Administration of Platelet Rich Plasma Versus Hyaluronic Acid as Placebo in Patients With Osteoarthritis of Knee

Dr. Himanshu Bansal Foundation0 个研究点目标入组 100 人开始时间: 2014年10月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
100
主要终点
changes in womac score

研究概览

简要总结

Randomized, Double-blind, 12-month, placebo-controlled study was conducted on 100 outpatients . Intervention platelet rich plasma( PRP) prepared from 60 ml of blood by adding novel step of filtration to manual centrifuge step to achieve 7 times concentration. the efficacy was compared with administration of hyaluronic acid. Subjective Womac scores ,6 min pain free walking distance as well objective assessments MRI ,synovial fluid assessments were made out .Absolute counts of platelets as dose was evaluated to be effective in alleviating symptoms in early knee OA.

详细描述

Osteoarthritis (OA) causes substantial physical disability that limits a person ability to indulge in daily activities. OA related disability has been affecting millions of older adults throughout the world, and the number has almost doubled in 2019.

Though the process of OA could not be reversed, efficient management strategies could help in minimizing primary pain with physical exercises, surgical procedures, and medications.

Prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) has been dramatically associated with mild to severe side effects, limiting its continuous use. Chondro-protective agents (CPAs) have been proven to provide only minimal symptomatic benefit. Platelet-rich plasma (PRP) has emerged as a supreme therapy in OA knee however exact dose ,preparation and duration of benefit still remains unclear.

Study was undertaken to demonstrate the potential of leukocyte depleted PRP in cartilage repair of knee OA using WOMAC scores as subjective assessment tool.

Our research also evaluated objective criteria ing joint space width (JSW),cartilage thickness on MRI, Ultrasound that would improve knee joint function in patients with knee OA.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Hyaluronic acid as placebo both patient and investigator blinded

入排标准

年龄范围
25 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Outpatients who fulfilled the clinical and radiological criteria set by the American College of Rheumatology for the diagnosis of symptomatic primary knee OA, with pain Visual Analogue Scale (VAS) score of >3 in the previous month. In cases where both the knees were symptomatic, the knee which was comparatively more painful was considered.

排除标准

  • Evidence of secondary knee OA because of injury, inflammatory or metabolic rheumatic disease, or osteonecrosis;
  • Prior intra-articular injection of hyaluronic acid (HA), including lavage and corticosteroids within the previous three months;
  • Severe knee OA, with JSW <1 mm, or surgery required on the evaluated knee in the year
  • Patients with clinically significant systemic disease.

研究组 & 干预措施

PRP (100billion platelets)

Experimental

platelet rich plasma having 100 billion platelets in 10 ml plasma prepared from 60 ml blood

干预措施: Platelet rich plasma (Biological)

hyaluronic acid

Placebo Comparator

Four ml of high-molecular-weight hyaluronic acid (HMWHA) with a concentration of 22mg/ml

干预措施: Hyaluronic Acid (Drug)

结局指标

主要结局

changes in womac score

时间窗: baseline,1 month,3 months,6 months, and 1year

WOMAC, a widely used measure to assess patients' pain, joint mobility, and physical disability evaluates three dimensions, pain, stiffness, and physical function, with 5, 2, and 17 questions, respectively. The total maximum score is 96 and minimum, 0

changes in cartilage thickness as assessed on 1.5 T MRI

时间窗: baseline and at one year

Using the 1.5-T field strength with standard MRI acquisition protocols, MRI was performed of each joint individually in coronal, sagittal, and transverse planes. The maximum thickness of the cartilage at posterior,meniscal and patellar level measured at the midsagittal plane through the medial condyle was considered. The medial femoral cartilage of the affected knee was chosen for measurement.

次要结局

  • changes in joint space width(baseline and at 12months)
  • changes in cartilage thickness as assessed by ultrasonically.(baseline ,6 months and at 12 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

To Evaluate the Optimum Dose of Platelet Rich Plasma... | 临床试验